BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 6, 2003
View Archived Issues
MorphoSys and Schering AG collaboration yields positive animal data
Read More
MedImmune and Critical Therapeutics to develop drugs targeting HMGB-1
Read More
Fulvestrant at least as effective as anastrozole in advanced breast cancer
Read More
Ariad summarizes recent important findings
Read More
FDA requests additional information in support of Hemopure BLA
Read More
GPC Biotech makes progress on various fronts with 1D09C3
Read More
Happy Valley Medical licenses Ceracor to Edwards Lifesciences
Read More
NeoGenesis and Amgen form R&D collaboration
Read More
Squalamine improves visual outcomes in phase I/II wet AMD study
Read More
CV Therapeutics and FDA agree to cancel Ranexa review
Read More
Chiron licenses HCV technology to Gilead for drug development efforts
Read More
Novel HCV NS3 protease inhibitors under study at BMS
Read More
Antibacterial quaternary ammonium salts, their preparation and use reported by Toagosei
Read More
JT patent covers new inhibitors of sodium-phosphate cotransporter and their use
Read More
Two novel series of lanosterol synthase inhibitors in early development at Roche
Read More
New antitumor agents in Kyowa Hakko development pipeline
Read More
ARS scientists design GILZ-based peptides for use in cancer, inflammation, etc.
Read More
Irreversible inhibition of CYP3A4 described for tabimorelin in humans
Read More
Astralis cleared to begin phase I testing of Psoraxine in U.S.
Read More
Submission of European MAA, U.S. sNDA for Angiomax
Read More
FDA approves Photofrin PDT for high-grade dysplasia in Barrett's esophagus
Read More
Novel antibiotics targeting pantothenate kinase
Read More
Kirin Brewery licenses antibody technology to Takeda
Read More